Skip to main content
. 2023 Mar 7;14:1112513. doi: 10.3389/fimmu.2023.1112513

Figure 4.

Figure 4

Comparative diagram of in vivo / ex vivo gene deliveries. In-vivo gene delivery via the use of nanoparticles. Conjugation of the nanoparticle designed for the target cell and the siRNA designed against the targeted genetic material are applied to the patient based of disease characteristics (i.e topical application for HPV infected cervical cells). Ex-vivo gene delivery via the use of lentiviral vectors requiring the collection of patient cells, transduction with the constructed lentiviral vector before re-introduction of the transduced patient cells back into the patient. Created with BioRender.com.